Congratulation to Sir Gregory Winter, our advisory board chair and speaker at past GapSummits, for jointly winning the 2018 Nobel Prize in Chemistry.
Sir Greg has been jointly awarded this year’s prize with George Smith and Frances Arnold, for developing a method known as phage display and using it for the directed evolution of antibodies, which have resulted in new therapies for a range of diseases.
"It came as a bit of a shock, and I felt a bit numb for a while. It's almost like you're in a different universe," – Greg Winter, on hearing he had been awarded the Nobel Prize
The first pharmaceutical based on phage display, adalimumab, was approved in 2002 for the treatment of rheumatoid arthritis. Since then, this pioneering method has produced antibodies that can neutralise toxins, counter-act autoimmune diseases and fight against metastatic cancer, and today accounts for a third of all new treatments.
To find out more about Sir Gregory’s research career and his reaction to winning this prestigious prize:
Sir Greg has been presented with many awards for his work including the 2013 Gairdner Foundation International Award, the MRC’s 2013 Millennium Medal, and the Cancer Research Institute’s William B. Coley Award in 1999. He is a Fellow of the Royal Society and of the Academy of Medical Sciences and has been Master of Trinity College, Cambridge since 2012, receiving a Knighthood for services to Molecular Biology in 2004.
We also want to take this special opportunity to thank Sir Greg for his generous support of Global Biotech Revolution and our mission sharing his experiences and insights, as well as helping us shape the next generation of biotech leaders thorough speaking at GapSummits.